Compare · ALXN vs MYOS
ALXN vs MYOS
Side-by-side comparison of Alexion Pharmaceuticals, Inc. (ALXN) and MYOS RENS Technology Inc. (MYOS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALXN and MYOS operate in Major Pharmaceuticals (Health Care), so they compete in similar markets.
- Company
- Alexion Pharmaceuticals, Inc.
- MYOS RENS Technology Inc.
- Price
- -
- -
- Market cap
- -
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Major Pharmaceuticals
- Major Pharmaceuticals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1996
- n/a
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 0
Latest ALXN
- Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer
- SEC Form 15-12G filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
- SEC Form EFFECT filed by Alexion Pharmaceuticals, Inc.
Latest MYOS
- MedAvail and MYOS RENS Technology Announce Closing of Business Combination
- MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding
- MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger
- MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020
- INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - MVC, ARA, YIN, MYOS